Power Heart Consortium, a Korean private equity group, invested in Cleveland Heart, which is a joint venture between Cleveland Clinic and medical technology company TransWorld Medical Devices.
Cleveland Heart, a spin-off company from US-based medical research institute Cleveland Clinic’s Innovations corporate venturing unit, has raised $30m in its series A round to develop and test an artificial heart. Power Heart Consortium, a Korean private equity group, invested in Cleveland Heart, which is a joint venture between Cleveland Clinic and medical technology company…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
